Predicting the incidence and timing of central nervous system disease in metastatic melanoma: Implications for surveillance and preventative therapy

J Am Acad Dermatol. 2018 Feb;78(2):419-421. doi: 10.1016/j.jaad.2017.07.059.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Antineoplastic Agents, Immunological / therapeutic use
  • Brain Neoplasms / prevention & control
  • Brain Neoplasms / secondary*
  • Disease-Free Survival
  • Extremities
  • Female
  • Humans
  • Ipilimumab / therapeutic use
  • Male
  • Melanoma / drug therapy
  • Melanoma / pathology*
  • Melanoma / secondary*
  • Population Surveillance*
  • Risk Factors
  • Sex Factors
  • Skin Neoplasms / drug therapy
  • Skin Neoplasms / pathology*
  • Skin Ulcer / etiology
  • Survival Rate

Substances

  • Antineoplastic Agents, Immunological
  • Ipilimumab